Melbourne Clinical Trials

The Neuron Study

The study drug is a potential new treatment for various neuropathies & neurodegenerative conditions

5 nights
1 visits

Study Objective:

  • The study medication is a potential new treatment for various neurological conditions, including neurodegeneration (diseases that affect the nerve cells of the brain) and glaucoma.
  • The study will provide crucial information on the safety, tolerability, and effectiveness of the study medication in humans, paving the way for future clinical use.

Importance of Treatment:

  • If successful the study medication could become a valuable therapy for neurodegenerative conditions, which currently lack effective treatments.
  • The study medication works by inhibiting a specific naturally occurring protein, which may protect nerve fibers from degeneration, potentially benefiting patients with various neurodegenerative diseases, including ALS.

Clinical Trial Details:

  • An independent ethics committee has approved this clinical trial.
  • Participants will be reimbursed for their time.

Call us on 1800 243 733 to discuss your eligibility today!

Eligibility

Biological Sex Male or Female
Age 18 – 55 years old
BMI 18 - 32 kg/m²
Weight >50kg
Medical History No significant medical history
Medications Not taking any prescription medication
Smoking History Non-smokers or smoking 5 or less cigarettes/day